InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| TLR4-based adjuvant - MPLA-SM VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| Pam3CSK4 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| R848 VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| Poly(I:C) (HMW) VacciGrade™ | The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combi... | 2021 | Pharmaceutics. | Jia Y. et al. | DOI: 10.3390/pharmaceutics13020205 |
| ODN 2088 | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |
| ODN 2088 control | Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosi... | 2021 | Front. Cell Dev. Biol. | Zheng H. et al. | DOI: 10.3389/fcell.2021.641527 |
| Primocin® | PINK1-mediated inhibition of EGFR dimerization and activation impedes EGFR-dr... | 2021 | Cancer Res. | Lin E.P.Y. et al. | DOI: 10.1158/0008-5472.CAN-20-2582 |
| Normocure™ - Antimicrobial Reagent | Establishing Human Intestinal Enteroid/Organoid Lines from Preterm Infant and... | 2020 | Methods Mol Biol. | Stewart C.J. et al. | DOI: 10.1007/978-1-0716-0338-3_16 |
| Pan-Caspase inhibitor - Z-VAD-FMK | Apoptotic effects of dehydrocrenatidine via JNK and ERK pathway regulation in... | 2021 | Biomed Pharmacother. | Ho H.Y. et al. | DOI: 10.1016/j.biopha.2021.111362 |
| Normocure™ - Antimicrobial Reagent | A non-invasive method to generate induced pluripotent stem cells from primate... | 2021 | Sci Rep. | Geuder J. et al. | DOI: 10.1038/s41598-021-82883-0 |
| Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Smectite promotes probiotic biofilm formation in the gut for cancer immunothe... | 2021 | Cell Rep. | Han C. et al. | DOI: 10.1016/j.celrep.2021.108706 |
| Mouse TLR2 Reporter HEK293 Cells (NF-κB) | Smectite promotes probiotic biofilm formation in the gut for cancer immunothe... | 2021 | Cell Rep. | Han C. et al. | DOI: 10.1016/j.celrep.2021.108706 |
| THP1-Lucia™ ISG Cells | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
| IFN-α/β Reporter HEK 293 Cells | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
| QUANTI-Luc™: Luciferase Detection Reagent | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
| QUANTI-Blue™ | Vpx enhances innate immune responses independently of SAMHD1 during HIV-1 inf... | 2021 | Retrovirology | Cingöz O. et al. | DOI: 10.1186/s12977-021-00548-2 |
| Ramos-Blue™ Cells | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
| Recombinant human CD40L protein | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
| Zeocin® | Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic ... | 2021 | Mol. Ther. | Ylösmäki E. et al. | DOI: 10.1016/j.omto.2021.02.006 |
| Tri-DAP | Human SLC15A4 is crucial for TLR-mediated type I Interferon production and mi... | 2021 | Int Immunol. | Kobayashi T. et al. | DOI: 10.1093/intimm/dxab006 |